Agilisium Recognized as a Leader in Everest Group Life Sciences Digital Services for Mid-Market Enterprises PEAK Matrix® Report

Los Angeles, August 19^th, 2024 – Agilisium, a premier digital innovation partner for Life Sciences companies, today announced that it has been chosen as a leader by the Everest Group in their Life Sciences Digital Services for Mid-Market Enterprises PEAKMatrix® Assessment report, 2024. The assessment study involved the evaluation of the vision, capability (strategy, scope of services, innovation, delivery footprint), and market impact (market adoption, portfolio mix, and value delivered) of over 26 niche providers and their range of offerings for LifeSciences enterprises globally.

Life Sciences mid-market enterprises are agile, have ambitious growth plans, and look for innovation-led differentiation to create value. Agilisium’s values resonate with their expectations and is one of their proud partners. To this end, the Everest Group evaluated Agilisium’s comprehensive capabilities across the Life Sciences value chain—including discovery, clinical trials, manufacturing, sales, and marketing—along with client case studies and references.

Download Full Report

“Being recognized as a leader by an independent research firm, the Everest Group, is a significant testament in our commitment to delivering superior digital solutions that address the pressing needs of the Life Sciences industry. It is also a validation of Agilisium’s specialized expertise leveraging our digital services for the Life Sciences industry,” said Raj Babu, Founder and CEO of Agilisium. He further added, “To specifically address the unique needs of mid-market enterprises, backed by data across Life Science functions, Agilisium has created a collaborative eco-system that brings together leading life sciences-centric partners, technology majors, academia, and research institutions. It has also invested significantly in Agilisium Labs, a dedicated innovation sandbox that focuses on building advanced analytics and Gen AI solutions across the Life Sciences value chain.”  

“Mid-market Life Science enterprises face unique challenges that distinguish them from their larger counterparts, necessitating distinct sourcing needs, such as client intimacy, agility, and cost-effective innovation, to stay competitive. Recognizing these specific needs, providers are tailoring their strategies to offer personalized support and innovative solutions, capitalizing on the increasing mid-market demand. Agilisium’s investments in building domain-specific IP, and innovation labs, complemented by its commitment to proactively deliver value in client engagements, has helped them earn a leading position in Everest Group’s Life Sciences Digital Services for Mid-market Enterprises PEAK Matrix® Assessment2024,” says Durga Ambati, Practice Director at Everest Group.

Agilisium counts seven of the top 10 mid-market life sciences companies as its clients. The company has brought onboard seasoned technology and domain experts, attracting senior talent from some of the top Life Sciences companies such as Novartis, Amgen, Bayer, UCB, and Sanofi to build next-generation solutions that address the structural shifts in the industry.

‍About Agilisium  

Agilisium is is a leading digital innovation partner in the Life Sciences sector. The company delivers cutting-edge solutions that drive impactful change by combining strong domain expertise with advanced technologies in Data, Cloud, Gen AI, and Advanced Analytics.

Agilisium collaborates with top pharmaceutical and biotech companies to enhance the entire value chain with data-driven insights and innovative solutions, accelerating drug discovery, optimizing patient care, driving commercial success, streamlining product delivery, and fostering collaboration. Learn more at www.Agilisium.com